The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: Data from the Heart and Soul Study

American Heart Journal

Volumn 162, Issue 3, 2011, Pages 555-561

  Welles, Christine C ^a   Whooley, Mary A ^a,b   Na, Beeya ^b   Ganz, Peter ^a,c   Schiller, Nelson B ^a   Turakhia, Mintu P ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN ISCHEMIA; CALCULATION; CHADS 2 SCORE; CLINICAL ASSESSMENT TOOL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STROKE; TRANSIENT ISCHEMIC ATTACK; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; INCIDENCE; MENTAL STRESS; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 80052327242     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.05.023     Document Type: Article

References (40)

1. B.F. Gage Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
2. A.J. Camm, P. Kirchhof, and G.Y.H. Lip Guidelines for the management of atrial fibrillation Eur Heart J 31 2010 2369 2429
3. D. Singer, G. Albers, and J. Dalen American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines Chest 133 2008 546S 592S (Pubitemid 351892972)
4. V. Fuster, L. Ryden, and D. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm association and the Heart Rhythm Society Circulation 114 2006 e257
5. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics-2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee Circulation 119 2009 e21 e181
6. S. Yusuf, P. Sleight, and J. Pogue Heart Outcomes Prevention Evaluation Study. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153 (Pubitemid 30051645)
7. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease-Framingham Study JAMA 241 1979 2035 2038
8. E. Loh, M.S.J. Sutton, and C.C.C. Wun Ventricular dysfunction and the risk of stroke after myocardial infarction N Engl J Med 336 1997 251 257 (Pubitemid 27044626)
9. B. Ruo, J.S. Rumsfeld, and M.A. Hlatky Depressive symptoms and health-related quality of life: the Heart and Soul Study JAMA 290 2003 215 221 (Pubitemid 37430060)
10. Atrial Fibrillation Investigators Atrial Fibrillation A, Anticoagulation Study, Boston Area Anticoagulation Trial for Atrial Fibrillation Study, Canadian Atrial Fibrillation Anticoagulation Study, Stroke Prevention in Atrial Fibrillation Study, Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Study. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
11. K. Asplund, R. Bonita, and K. Kuulasmaa Multinational comparisons of stroke epidemiology: evaluation of case ascertainment in the WHO MONICA stroke study Stroke 26 1995 355
12. P. Thorvaldsen, K. Asplund, and K. Kuulasmaa Stroke incidence, case fatality, and mortality in the WHO MONICA project Stroke 26 1995 361
13. P. Wolf, R. D'Agostino, and W. Kannel Cigarette smoking as a risk factor for stroke: the Framingham Study JAMA 259 1988 1025
14. H.C. Bucher, L.E. Griffith, and G.H. Guyatt Effect of HMG-CoA reductase inhibitors on stroke Ann Intern Med 128 1998 89 95
15. R.G. Hart, O. Benavente, and R. McBride Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis Ann Intern Med 131 1999 492
16. H. Nakashima, K. Kumagai, and H. Urata Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation Circulation 101 2000 2612
17. T. Tsang, M. Barnes, and W. Abhayaratna Effects of quinapril on left atrial structural remodeling and arterial stiffness Am J Cardiol 97 2006 916 920
18. D. Schoenfeld Partial residuals for the proportional hazards regression model Biometrika 69 1982 239 241
19. P. Grambsch, and T. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515
20. G. Lip, R. Nieuwlaat, and R. Pisters Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach Chest 137 2010 263
21. R. D'Agostino, P. Wolf, and A. Belanger Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study Stroke 25 1994 40
22. T. Wang, J. Massaro, and D. Levy A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study JAMA 290 2003 1049
23. M. Fang, A. Go, and Y. Chang Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation J Am Coll Cardiol 51 2008 810 815 (Pubitemid 351253746)
24. 2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation Am Heart J 157 2009 e9
25. J.I. Haft, and L.E. Teichhoz Echocardiographic and clinical risk factors for atrial fibrillation in hypertensive patients with ischemic stroke Am J Cardiol 102 2008 1348 1351
26. T. Watson, E. Shantsila, and G. Lip Mechanisms of thrombogenesis in atrial fibrillation Virchow's triad revisited. Lancet 373 2009 155
27. A. Chong, A. Blann, and J. Patel Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide Circulation 110 2004 1794
28. Y.H.L. Gregory, D.B. Andrew, and F.J. Alan Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy Am J Cardiol 80 1997 1566 1571
29. J. McClung, N. Naseer, and M. Saleem Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA1c Diabetologia 48 2005 345 350 (Pubitemid 40543308)
30. A. Choudhury, I. Chung, and A.D. Blann Platelet surface cd62p and cd63, mean platelet volume, and soluble/platelet p-selectin as indexes of platelet function in atrial fibrillatio-a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm J Am Coll Cardiol 49 2007 1957 1964 (Pubitemid 46695928)
31. G. Casaclang-Verzosa, B.J. Gersh, and T.S.M. Tsang Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation J Am Coll Cardiol 51 2008 1 11
32. M. Barnes, Y. Miyasaka, and J. Seward Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation Mayo Clin Proc 79 2004 1008
33. S. Vaziri, M. Larson, and E. Benjamin Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study Circulation 89 1994 724 730 (Pubitemid 24056200)
34. G. Casaclang-Verzosa, M.E. Barnes, and G. Blume C-reactive protein, left atrial volume, and atrial fibrillation: a prospective study in high-risk elderly Echocardiography 27 2010 394 399
35. L.R. Peterson, A.D. Waggoner, and L. de las Fuentes Alterations in left ventricular structure and function in type-1 diabetics: a focus on left atrial contribution to function J Am Soc of Echocardiogr 19 2006 749 755 (Pubitemid 43817468)
36. P. Sanders, J.B. Morton, and N.C. Davidson Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans Circulation 108 2003 1461 1468 (Pubitemid 37176452)
37. T.S.M. Tsang, M.E. Barnes, and B.J. Gersh Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden Am J of Cardiol 90 2002 1284 1289 (Pubitemid 35449471)
38. K. Furie, S. Kasner, and R. Adams Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 227 276
39. L. Goldstein, C. Bushnell, and R. Adams Guidelines for the primary prevention of stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 227 276
40. D.A. Fitzmaurice, F. Hobbs, and S. Jowett Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial BMJ 335 2007 383 386 (Pubitemid 47359316)